{"protocolSection":{"identificationModule":{"nctId":"NCT04926142","orgStudyIdInfo":{"id":"2020-A03417-32"},"organization":{"fullName":"Centre Hospitalier Universitaire de Besancon","class":"OTHER"},"briefTitle":"Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study","officialTitle":"Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study","acronym":"PFO-AF"},"statusModule":{"statusVerifiedDate":"2024-01","overallStatus":"ACTIVE_NOT_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-07-05","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-08-21","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2021-06-11","studyFirstSubmitQcDate":"2021-06-11","studyFirstPostDateStruct":{"date":"2021-06-14","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-01-31","lastUpdatePostDateStruct":{"date":"2024-02-01","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Centre Hospitalier Universitaire de Besancon","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study aims to assess the incidence of atrial fibrillation (AF), documented using data recorded by an implantable Holter monitoring device (Reveal Linq, Medtronic) within 2 years after percutaneous closure of patent foramen ovale for cryptogenic stroke.","detailedDescription":"This study aims to assess the incidence of atrial fibrillation (AF), documented using data recorded by an implantable Holter monitoring device (Reveal Linq, Medtronic) within 2 years after percutaneous closure of patent foramen ovale (PFO) for cryptogenic stroke. Secondary objectives include assessment of the burden of AF at 2, 12 and 24 months after PFO closure; evaluation of the relationship between plasma levels of MR proANP and presence of AF within 2 years after percutaneous PFO closure in patients with a history of cryptogenic ischemic stroke; and description of recurrence rates for stroke (ischemic and hemorrhagic), major bleeding, minor bleeding, peripheral emboli during the 2-year follow-up period after percutaneous PFO closure, in patients with and without AF."},"conditionsModule":{"conditions":["Patent Foramen Ovale","Atrial Fibrillation","Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":250,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Patients planned for percutaneous PFO closure","description":"Patients will undergo implantation of a Holter device (Reveal Linq Medtronic) 2 months prior to percutaneous PFO closure. Devices will be monitored by telemonitoring until the PFO closure procedure, and at 2, 12 and 24 months after the procedure.","interventionNames":["Device: Implantation of Holter device","Procedure: Percutaneous PFO closure"]}],"interventions":[{"type":"DEVICE","name":"Implantation of Holter device","description":"Implantation of a Holter device (Reveal Linq, Medtronic) for telemonitoring of cardiac rhythm","armGroupLabels":["Patients planned for percutaneous PFO closure"]},{"type":"PROCEDURE","name":"Percutaneous PFO closure","description":"Patients will undergo percutaneous closure of patent foramen ovale","armGroupLabels":["Patients planned for percutaneous PFO closure"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Atrial fibrillation","description":"Occurrence of documented atrial fibrillation (i.e. at least one episode lasting 30 seconds)","timeFrame":"Within 2 months after percutaneous PFO closure"}],"secondaryOutcomes":[{"measure":"Atrial fibrillation","description":"Occurrence of documented atrial fibrillation (i.e. at least one episode lasting 30 seconds)","timeFrame":"Within 24 months after percutaneous PFO closure"},{"measure":"Burden of atrial fibrillation","description":"Cumulative total time in atrial fibrillation (in days, hours, minutes)","timeFrame":"Within 2 years after percutaneous PFO closure"},{"measure":"Relation between MR proANP levels and atrial fibrillation","description":"Relation between pre-procedure circulating venous MR proANP levels and atrial fibrillation defined as per the primary endpoint","timeFrame":"Within 2 years after percutaneous PFO closure"},{"measure":"Stroke","description":"Ischemic or hemorrhagic stroke documented by CT or MRI","timeFrame":"Within 2 years after percutaneous PFO closure"},{"measure":"Peripheral emboli","description":"Peripheral emboli by CT or MRI","timeFrame":"Within 2 years after percutaneous PFO closure"},{"measure":"Bleeding","description":"Major or minor bleeding according to the ISTH classification","timeFrame":"Within 2 years after percutaneous PFO closure"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adult patients (aged \\>18 years)\n* with an indication for percutaneous closure of PFO due to cryptogenic stroke, with indication validated by a cardio-neurological team.\n* patients must provide written informed consent\n* patients must be affiliated to a social security regime or be a beneficiary thereof.\n\nExclusion Criteria:\n\n* Patients under legal protection\n* Patients not affiliated to any social security regime\n* Patients within the exclusion period of another clinical trial as per the national registry of research volunteers","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Prospective patients who have had cryptogenic stroke (ischemic only) and with patent foramen ovale confirmed by transoesophageal echocardiography, with an indication for percutaneous closure.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Marc Badoz, MD","affiliation":"Centre Hospitalier Universitaire de Besancon","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"University Hospital Besancon","city":"Besançon","zip":"25000","country":"France","geoPoint":{"lat":47.24878,"lon":6.01815}},{"facility":"CHU Lyon - Hôpital Louis Pradel","city":"Bron","country":"France","geoPoint":{"lat":45.73333,"lon":4.91667}},{"facility":"CHU Dijon","city":"Dijon","country":"France","geoPoint":{"lat":47.31667,"lon":5.01667}},{"facility":"CHU Grenoble","city":"Grenoble","country":"France","geoPoint":{"lat":45.16667,"lon":5.71667}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000001281","term":"Atrial Fibrillation"},{"id":"D000054092","term":"Foramen Ovale, Patent"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000006344","term":"Heart Septal Defects, Atrial"},{"id":"D000006343","term":"Heart Septal Defects"},{"id":"D000006330","term":"Heart Defects, Congenital"},{"id":"D000018376","term":"Cardiovascular Abnormalities"},{"id":"D000000013","term":"Congenital Abnormalities"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M27260","name":"Foramen Ovale, Patent","asFound":"Patent Foramen Ovale","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Cryptogenic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M9122","name":"Heart Septal Defects, Atrial","relevance":"LOW"},{"id":"M9121","name":"Heart Septal Defects","relevance":"LOW"},{"id":"M9108","name":"Heart Defects, Congenital","relevance":"LOW"},{"id":"M12","name":"Congenital Abnormalities","relevance":"LOW"},{"id":"M20193","name":"Cardiovascular Abnormalities","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"}]}},"hasResults":false}